Synthaverse S.A. (WSE: SVE)
Poland
· Delayed Price · Currency is PLN
4.370
-0.045 (-1.02%)
Nov 21, 2024, 5:00 PM CET
Synthaverse Revenue
Synthaverse had revenue of 13.41M PLN in the quarter ending September 30, 2024, with 65.45% growth. This brings the company's revenue in the last twelve months to 62.66M, up 18.75% year-over-year. In the year 2023, Synthaverse had annual revenue of 58.61M with 16.32% growth.
Revenue (ttm)
62.66M
Revenue Growth
+18.75%
P/S Ratio
n/a
Revenue / Employee
262.16K
Employees
239
Market Cap
306.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 58.61M | 8.22M | 16.32% |
Dec 31, 2022 | 50.38M | 9.23M | 22.43% |
Dec 31, 2021 | 41.15M | 995.00K | 2.48% |
Dec 31, 2020 | 40.16M | 1.05M | 2.69% |
Dec 31, 2019 | 39.11M | 6.81M | 21.10% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Krka, d. d. | 8.14B |
NEUCA S.A. | 12.34B |
Sopharma AD | 4.35B |
Synektik Spólka Akcyjna | 624.80M |
Celon Pharma S.A. | 206.81M |
Voxel S.A. | 476.19M |
Ryvu Therapeutics S.A. | 91.18M |
Selvita S.A. | 329.02M |